Volver a Agenda
Session Chair(s)
Royce A. Morrison, MD, MS, FACP
Senior Consultant
Pacific Pharma Group, LLC, United States
Learning Objective : Define pharmacometrics and describe examples of its application across the range of drug development and decision-making activities; Explain the need for all decision-makers in drug development to know how and when to implement pharmacometric methods.
Speaker(s)
Clinical Implications of Population Pharmacokinetics of rFIXFc in Management of Hemophilia B
Haiyan Jiang, PHD
Biogen Idec, United States
Senior Director, Preclinical and Clinical Research (Hemophilia)
Seeing into the Future: The Prasugrel Story of Pharmacometric Support for Dose Adjustments in Higher-risk Subgroups
David S. Small, PHD
Eli Lilly and Company, United States
Research Advisor, Global Pharmacokinetics/Pharmacodynamics
Impact of Pharmacometrics on Pediatric Drug Development
Amit Roy
Bristol-Myers Squibb Company, United States
Group Director, Clinical Pharmacology and Pharmacometrics R&D
¿Tiene una cuenta?